Stock Quality:
Last 7 days
-6.3%
Last 30 days
-21.7%
Last 90 days
-23.1%
Trailing 12 Months
-21.7%
MXCT RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Revenue Breakdown
| |||||||||||||||
|
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 44.1M | 45.4M | 45.6M | 38.6M |
2023 | 41.2M | 40.7M | 38.0M | 41.3M |
2022 | 39.0M | 41.5M | 42.0M | 44.3M |
2021 | 26.9M | 28.9M | 32.3M | 33.9M |
2020 | 0 | 23.1M | 24.7M | 26.2M |
2019 | 0 | 0 | 0 | 21.6M |
CEO | Mr. Douglas Arthur Doerfler |
---|---|
WEBSITE | https://maxcyte.com |
SECTOR | Healthcare |
INDUSTRY | Medical Devices |
EMPLOYEES | 125 |